. . . . . "Dextroamphetamine sulfate" . "biolink:ChemicalEntity" . "UMLS:C0011810" . . "Attention Deficit Disorder with Hyperactivity" . "biolink:DiseaseOrPhenotypicFeature" . "MONDO:0005302" . . . . . . "biolink:Association" . "collaboratory:UMLS:C0011810-biolink:treats-MONDO:0005302" . . . "biolink:Publication" . "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40" . . "biolink:InformationResource" . "infores:knowledge-collaboratory" . "67"^^ . . "112"^^ . "Attention Deficit Disorder with Hyperactivity" . . . "0"^^ . . "25"^^ . "Dextroamphetamine sulfate" . . . "2023-02-27T16:53:35.642515"^^ . . . "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQD3RHyHR7WWKBYevw1qK86B6RVzI7oKlvghqXvbpOAX1KueDE6Itru34HRhrVy4OMLCRQWBE3VXktKdbgOxD3vC4cIxz5LX+XOgGWzv5WKSjOfXu/yIeJrzsuIkyHvw7/tToGrE0itJ1wGylJv+YieizmGvNiUHhP0J0+YFMNnvewIDAQAB" . "xPLfAYF36ov6tLHrPAI9T0RjKCNtHIubj3WrIissgchN+/CtvpptDPAZRG4O+XThEVTja1ap+pDk8uyze+g4kGm420KC3mWEZ2117na3v9Ow1O55/TRyYJH9Vq2IRajHORO4zNy5c5GAmbuFzk2S3WujAlvVMeaDxybjcq4d164=" . . . "2023-02-27T16:53:35.642515"^^ . . "3.1.0" .